Biogen INC.
Forward trial catalysts linked to BIIB
CSA tracks 1 forward catalyst for Biogen INC. across 1 asset, spanning Phase 2/3. The nearest is a readout expected Oct 20, 2026 (day precision). Confidence across its tracked catalysts breaks down as 1 medium. Tracked indications include Lupus Erythematosus, Systemic, Systemic Lupus Erythematosus (SLE), Subacute Cutaneous Lupus Erythematosus.
BIIB in the full snapshot
The free sample on this page is a slice. In the current full CSA snapshot, Biogen INC. has:
Forward catalysts by year
Every catalyst in the snapshot comes with its date, date confidence and source link.
5 trials behind these assets
| Asset | Trial | Phase | Status | Primary completion | Role | Lead sponsor | Condition(s) |
|---|---|---|---|---|---|---|---|
| litifilimab | NCT04961567 | Phase 3 | Active, not recruiting | 2026-09-27 | Experimental | Biogen | Lupus Erythematosus, Systemic |
| litifilimab | NCT04895241 | Phase 3 | Active, not recruiting | 2026-09-30 | Experimental | Biogen | Lupus Erythematosus, Systemic |
| litifilimab | NCT05531565 catalyst | Phase 2/3 | Active, not recruiting | 2026-10-20 | Experimental | Biogen | Subacute Cutaneous Lupus Erythematosus; Chronic Cutaneous Lupus Erythematosus |
| litifilimab | NCT06044337 | Phase 3 | Enrolling by invitation | 2029-06-26 | Experimental | Biogen | Subacute Cutaneous Lupus Erythematosus; Chronic Cutaneous Lupus Erythematosus |
| litifilimab | NCT05352919 | Phase 3 | Enrolling by invitation | 2032-05-03 | Experimental | Biogen | Systemic Lupus Erythematosus (SLE) |
Every trial the CSA sample links to BIIB's tracked assets.
Conditions studied
Data, not investment advice. CSA is information, not a recommendation to buy, sell or hold any security. Estimated catalyst dates routinely slip and are graded by confidence — verify against the source link before acting.
This sponsor's catalysts are a slice of the free CSA sample. The full snapshot covers active, industry-sponsored Phase 3 trials in cardiometabolic, oncology and immunology. Every forward catalyst carries its date, confidence grade and source link, and is linked to its sponsor's ticker when the sponsor is a listed company.
Get the full dataset — $499 →